As of now, there are no specific antiviral treatments or vaccines available for oropouche virus.

Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...

An effective chikungunya vaccine would reduce the burden of acute infections and mitigate the substantial loss of economic productivity in working-age adults. In this trial, most adverse events were ...

The currently licensed JYNNEOS vaccine uses a "live attenuated" virus, meaning the virus has been weakened so it cannot cause disease in humans. That attenuation also limits its protective ...

The children’s story book Anna Hisbiscus’ Song written by the Nigerian-born author Atinuke has been wonderfully adapted for the stage and directed by Mojisola Kareem. Utopia Theatre and ...

Sept 3 (Reuters) - Vaxcyte's (PCVX.O), opens new tab shares surged as much as 48% to a record high on Tuesday after the company said its experimental pneumococcal vaccine showed promising results ...

As updated coronavirus vaccines hit U.S. pharmacy shelves, adults without health insurance are discovering the shots are no longer free, instead costing up to $200. The federal Bridge Access ...

Medical communities urge for vaccine approval During the inaugural Dengue Summit, health experts called on the Food and Drug Administration (FDA) to approve the second-generation vaccine against ...

The newest version of the COVID vaccine was approved by the U.S. Food and Drug Administration in August, and already landed in some Washington pharmacies last week. But local public health ...

The Vaccine and Infectious Disease Division’s (VIDD) strategy involves methodically uncovering findings in the laboratory that inform prevention studies in the clinic. Advanced statistical methods are ...

The One Show turned emotional as Springwatch host Chris Packham opened up on the “difficulty” of living with an incurable disease. Chris Packham presented an important segment on the BBC ...